This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the fi rst integrase inhibitor licensed to treat HIV-1 infection. ©Elsevier Editora Ltda.
CITATION STYLE
Hazuda, D. J. (2010). Resistance to inhibitors of the human immunodeficiency virus type 1 integration. Brazilian Journal of Infectious Diseases. Elsevier Editora Ltda. https://doi.org/10.1590/S1413-86702010000500016
Mendeley helps you to discover research relevant for your work.